Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
D000505:Alopecia / Q000139:chemically induced; D000630:Aminopterin / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D001379:Azathioprine / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects; D002066:Busulfan / Q000009:adverse effects; D002699:Chlorambucil / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003609:Dactinomycin / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005472:Fluorouracil / Q000009:adverse effects; D006177:Gynecomastia / Q000139:chemically induced; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D010787:Photosensitivity Disorders / Q000139:chemically induced; D010859:Pigmentation Disorders / Q000139:chemically induced; D011832:Radiation Injuries; D013280:Stomatitis / Q000139:chemically induced; D014747:Vinblastine / Q000009:adverse effects
D000970:Antineoplastic Agents; D001761:Bleomycin; D002699:Chlorambucil; D003609:Dactinomycin; D014747:Vinblastine; D003520:Cyclophosphamide; D001215:Asparaginase; D002066:Busulfan; D000630:Aminopterin; D001379:Azathioprine; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate